Barbara A. Weir

Weatherford College — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

52h-index43.8kcitations239works2.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(40), CRISPR and Genetic Engineering(28), Acute Myeloid Leukemia Research(27), Lung Cancer Treatments and Mutations(25), Cancer-related gene regulation(24)

Publications238 total

Comprehensive genomic dependency landscape of a human colon cancer organoid
Communications Biology·2025· 3 citedOpen Access
Editor’s Note: <i>PTEN</i> Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Cancer Research·2025Open Access
CRISPR/Cas9 Library Screens Identified <i>Atp2a2</i> As an <i>In Vivo</i> Specific Tumor Suppressor in Myeloid Neoplasms
Blood·2024Open Access
SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation
Cell Reports·2024· 8 citedOpen Access
Comprehensive Genomic Dependency Landscape of Human Colon Cancer
2024· 2 citedOpen Access
Abstract 897: Synthetic lethality screening with Recursive Feature Machines
Cancer Research·2024
SETDB1 Suppresses Interferon Responses and NK Cell-Mediated Immunosurveillance Specifically in Monocytic AML
Blood·2023Open Access
Supplementary Table S2 from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
2023Open Access
Supplementary Legends from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplemental Table 2 from The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
2023Open Access
Data from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
2023Open Access
Supplementary Figures S6 - S10 from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
2023Open Access
Supplementary Table S6 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Table S1 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Table S5 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Figure 2 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Table S7 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Table S8 from Systematic Interrogation of 3q26 Identifies &lt;i&gt;TLOC1&lt;/i&gt; and &lt;i&gt;SKIL&lt;/i&gt; as Cancer Drivers
2023Open Access
Supplementary Methods from Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
2023Open Access
Data from Identification of an “Exceptional Responder” Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy
2023Open Access
page 1 of 12Next →

Frequent Co-authors

William C. Hahn(29), Matthew Meyerson(22), David E. Root(18), Rameen Beroukhim(17), Aviad Tsherniak(17), Francisca Vázquez(17), Todd R. Golub(15), Levi A. Garraway(15), Jesse S. Boehm(14), Glenn S. Cowley(14), Gad Getz(12), Jill P. Mesirov(11), Pablo Tamayo(11), Craig H. Mermel(10), Wendy Winckler(8), Roman K. Thomas(7), Jordi Barretina(7), Levi D. Ali(7), Guozhi Jiang(7), Eric S. Lander(6)